Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 26.84
+1.22 (4.76%)
At close: Mar 6, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.84 billion as of March 6, 2026. Its market cap has increased by 7.40% in one year.
Market Cap
9.84B
Enterprise Value
8.57B
Revenue
230.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.84
Market Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.84B, a decrease of -21.11%. That is a compound annual growth rate of -8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.84B | -1.47% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 10.60B |
| Chengzhi | 10.52B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.40B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.27B |
| Liaoning Chengda Biotechnology | 10.25B |
| Aurisco Pharmaceutical | 10.13B |
| Chengdu Easton Biopharmaceuticals | 9.65B |
| Bio-Thera Solutions | 8.90B |